nodes	percent_of_prediction	percent_of_DWPC	metapath
Delavirdine—CYP3A7—Rifampicin—leprosy	0.0719	0.0837	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0719	0.0837	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0593	0.0691	CbGbCtD
Delavirdine—CYP3A7—Dapsone—leprosy	0.0593	0.0691	CbGbCtD
Delavirdine—CYP3A5—Thalidomide—leprosy	0.0557	0.0648	CbGbCtD
Delavirdine—CYP3A5—Rifampicin—leprosy	0.0539	0.0628	CbGbCtD
Delavirdine—CYP2C8—Rifampicin—leprosy	0.0518	0.0604	CbGbCtD
Delavirdine—CYP2C19—Thalidomide—leprosy	0.0449	0.0523	CbGbCtD
Delavirdine—CYP3A5—Dapsone—leprosy	0.0445	0.0518	CbGbCtD
Delavirdine—CYP2C19—Rifampicin—leprosy	0.0435	0.0506	CbGbCtD
Delavirdine—CYP2C8—Dapsone—leprosy	0.0428	0.0498	CbGbCtD
Delavirdine—CYP1A2—Thalidomide—leprosy	0.0414	0.0482	CbGbCtD
Delavirdine—CYP1A2—Rifampicin—leprosy	0.0401	0.0467	CbGbCtD
Delavirdine—CYP2C9—Thalidomide—leprosy	0.0373	0.0435	CbGbCtD
Delavirdine—CYP2C9—Rifampicin—leprosy	0.0361	0.0421	CbGbCtD
Delavirdine—CYP2C19—Dapsone—leprosy	0.0359	0.0418	CbGbCtD
Delavirdine—CYP2C9—Dapsone—leprosy	0.0298	0.0348	CbGbCtD
Delavirdine—CYP3A4—Rifampicin—leprosy	0.021	0.0245	CbGbCtD
Delavirdine—CYP3A4—Dapsone—leprosy	0.0174	0.0202	CbGbCtD
Delavirdine—Application site pruritus—Dapsone—leprosy	0.00723	0.0512	CcSEcCtD
Delavirdine—Acquired immunodeficiency syndrome—Thalidomide—leprosy	0.0045	0.0319	CcSEcCtD
Delavirdine—Lipase increased—Thalidomide—leprosy	0.00308	0.0218	CcSEcCtD
Delavirdine—Autoimmune disorder—Thalidomide—leprosy	0.00271	0.0192	CcSEcCtD
Delavirdine—Fungal skin infection—Thalidomide—leprosy	0.00216	0.0153	CcSEcCtD
Delavirdine—Proteinuria—Dapsone—leprosy	0.00201	0.0142	CcSEcCtD
Delavirdine—Protein urine present—Dapsone—leprosy	0.00198	0.014	CcSEcCtD
Delavirdine—Aphthous stomatitis—Thalidomide—leprosy	0.00193	0.0136	CcSEcCtD
Delavirdine—Neck stiffness—Thalidomide—leprosy	0.0019	0.0134	CcSEcCtD
Delavirdine—Peripheral vascular disorder—Thalidomide—leprosy	0.00184	0.013	CcSEcCtD
Delavirdine—Nuchal rigidity—Thalidomide—leprosy	0.00174	0.0123	CcSEcCtD
Delavirdine—Skin exfoliation—Dapsone—leprosy	0.00169	0.0119	CcSEcCtD
Delavirdine—Vesiculobullous rash—Thalidomide—leprosy	0.00161	0.0114	CcSEcCtD
Delavirdine—Toothache—Thalidomide—leprosy	0.00149	0.0105	CcSEcCtD
Delavirdine—Serum creatinine increased—Thalidomide—leprosy	0.00147	0.0104	CcSEcCtD
Delavirdine—Nail disorder—Thalidomide—leprosy	0.00139	0.00986	CcSEcCtD
Delavirdine—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00133	0.00938	CcSEcCtD
Delavirdine—Hepatomegaly—Thalidomide—leprosy	0.00128	0.00904	CcSEcCtD
Delavirdine—Nystagmus—Thalidomide—leprosy	0.00127	0.00895	CcSEcCtD
Delavirdine—Metrorrhagia—Thalidomide—leprosy	0.00127	0.00895	CcSEcCtD
Delavirdine—Hyperaesthesia—Thalidomide—leprosy	0.00115	0.00815	CcSEcCtD
Delavirdine—Rash pustular—Thalidomide—leprosy	0.00113	0.00802	CcSEcCtD
Delavirdine—Muscular weakness—Dapsone—leprosy	0.00113	0.008	CcSEcCtD
Delavirdine—Tingling sensation—Thalidomide—leprosy	0.00112	0.00796	CcSEcCtD
Delavirdine—Influenza—Dapsone—leprosy	0.00111	0.00784	CcSEcCtD
Delavirdine—Petechiae—Thalidomide—leprosy	0.0011	0.00777	CcSEcCtD
Delavirdine—Pancreatitis—Dapsone—leprosy	0.00109	0.00769	CcSEcCtD
Delavirdine—Vasodilation procedure—Thalidomide—leprosy	0.00103	0.00728	CcSEcCtD
Delavirdine—Vasodilation—Thalidomide—leprosy	0.00103	0.00728	CcSEcCtD
Delavirdine—Amenorrhoea—Thalidomide—leprosy	0.00103	0.00728	CcSEcCtD
Delavirdine—Proteinuria—Thalidomide—leprosy	0.00103	0.00728	CcSEcCtD
Delavirdine—Protein urine present—Thalidomide—leprosy	0.00101	0.00718	CcSEcCtD
Delavirdine—Musculoskeletal stiffness—Thalidomide—leprosy	0.00101	0.00713	CcSEcCtD
Delavirdine—Viral infection—Thalidomide—leprosy	0.001	0.00708	CcSEcCtD
Delavirdine—Bone disorder—Thalidomide—leprosy	0.001	0.00708	CcSEcCtD
Delavirdine—Hyperbilirubinaemia—Thalidomide—leprosy	0.000994	0.00703	CcSEcCtD
Delavirdine—Hypocalcaemia—Thalidomide—leprosy	0.000987	0.00699	CcSEcCtD
Delavirdine—Hyperuricaemia—Thalidomide—leprosy	0.000974	0.00689	CcSEcCtD
Delavirdine—Drug interaction—Thalidomide—leprosy	0.000974	0.00689	CcSEcCtD
Delavirdine—Neuropathy peripheral—Dapsone—leprosy	0.000968	0.00685	CcSEcCtD
Delavirdine—Bone pain—Thalidomide—leprosy	0.000944	0.00668	CcSEcCtD
Delavirdine—Sinusitis—Dapsone—leprosy	0.000927	0.00656	CcSEcCtD
Delavirdine—Blood uric acid increased—Thalidomide—leprosy	0.000921	0.00651	CcSEcCtD
Delavirdine—Coordination abnormal—Thalidomide—leprosy	0.000921	0.00651	CcSEcCtD
Delavirdine—Hyperkalaemia—Thalidomide—leprosy	0.000888	0.00628	CcSEcCtD
Delavirdine—Eructation—Thalidomide—leprosy	0.000888	0.00628	CcSEcCtD
Delavirdine—Pharyngitis—Dapsone—leprosy	0.00088	0.00623	CcSEcCtD
Delavirdine—Colitis—Thalidomide—leprosy	0.000868	0.00614	CcSEcCtD
Delavirdine—Candida infection—Thalidomide—leprosy	0.000863	0.00611	CcSEcCtD
Delavirdine—Skin exfoliation—Thalidomide—leprosy	0.000863	0.00611	CcSEcCtD
Delavirdine—Neuropathy—Thalidomide—leprosy	0.000849	0.00601	CcSEcCtD
Delavirdine—Dry eye—Thalidomide—leprosy	0.000835	0.00591	CcSEcCtD
Delavirdine—Cramps of lower extremities—Thalidomide—leprosy	0.00083	0.00588	CcSEcCtD
Delavirdine—Tinnitus—Dapsone—leprosy	0.000827	0.00585	CcSEcCtD
Delavirdine—Oesophagitis—Thalidomide—leprosy	0.000826	0.00584	CcSEcCtD
Delavirdine—Rash maculo-papular—Thalidomide—leprosy	0.000822	0.00581	CcSEcCtD
Delavirdine—Hypertonia—Thalidomide—leprosy	0.000792	0.00561	CcSEcCtD
Delavirdine—Mental disability—Thalidomide—leprosy	0.000784	0.00555	CcSEcCtD
Delavirdine—Euphoric mood—Thalidomide—leprosy	0.000777	0.0055	CcSEcCtD
Delavirdine—Erythema—Dapsone—leprosy	0.000772	0.00546	CcSEcCtD
Delavirdine—Lymphadenopathy—Thalidomide—leprosy	0.000769	0.00544	CcSEcCtD
Delavirdine—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000754	0.00534	CcSEcCtD
Delavirdine—Gastroenteritis—Thalidomide—leprosy	0.00074	0.00524	CcSEcCtD
Delavirdine—Vascular purpura—Thalidomide—leprosy	0.000734	0.00519	CcSEcCtD
Delavirdine—Vision blurred—Dapsone—leprosy	0.000727	0.00515	CcSEcCtD
Delavirdine—Injury—Thalidomide—leprosy	0.000714	0.00505	CcSEcCtD
Delavirdine—Renal failure acute—Thalidomide—leprosy	0.000711	0.00503	CcSEcCtD
Delavirdine—Libido decreased—Thalidomide—leprosy	0.000708	0.00501	CcSEcCtD
Delavirdine—Increased appetite—Thalidomide—leprosy	0.000698	0.00494	CcSEcCtD
Delavirdine—Amnesia—Thalidomide—leprosy	0.000698	0.00494	CcSEcCtD
Delavirdine—Dermatitis exfoliative—Thalidomide—leprosy	0.000695	0.00492	CcSEcCtD
Delavirdine—Vertigo—Dapsone—leprosy	0.000694	0.00491	CcSEcCtD
Delavirdine—Dermatitis bullous—Thalidomide—leprosy	0.000687	0.00486	CcSEcCtD
Delavirdine—Purpura—Thalidomide—leprosy	0.000681	0.00482	CcSEcCtD
Delavirdine—Arthritis—Thalidomide—leprosy	0.000675	0.00478	CcSEcCtD
Delavirdine—Cough—Dapsone—leprosy	0.000674	0.00477	CcSEcCtD
Delavirdine—Cardiac failure—Thalidomide—leprosy	0.000672	0.00476	CcSEcCtD
Delavirdine—Lethargy—Thalidomide—leprosy	0.00067	0.00474	CcSEcCtD
Delavirdine—Hyponatraemia—Thalidomide—leprosy	0.000659	0.00466	CcSEcCtD
Delavirdine—Diplopia—Thalidomide—leprosy	0.000656	0.00464	CcSEcCtD
Delavirdine—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000656	0.00464	CcSEcCtD
Delavirdine—Disturbance in sexual arousal—Thalidomide—leprosy	0.000651	0.00461	CcSEcCtD
Delavirdine—Affect lability—Thalidomide—leprosy	0.000646	0.00457	CcSEcCtD
Delavirdine—Migraine—Thalidomide—leprosy	0.000646	0.00457	CcSEcCtD
Delavirdine—Mood swings—Thalidomide—leprosy	0.000622	0.0044	CcSEcCtD
Delavirdine—Tachycardia—Dapsone—leprosy	0.000615	0.00435	CcSEcCtD
Delavirdine—Blood creatinine increased—Thalidomide—leprosy	0.000615	0.00435	CcSEcCtD
Delavirdine—Dry skin—Thalidomide—leprosy	0.000601	0.00426	CcSEcCtD
Delavirdine—Orthostatic hypotension—Thalidomide—leprosy	0.000599	0.00424	CcSEcCtD
Delavirdine—Cramp muscle—Thalidomide—leprosy	0.000591	0.00418	CcSEcCtD
Delavirdine—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000591	0.00418	CcSEcCtD
Delavirdine—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000591	0.00418	CcSEcCtD
Delavirdine—Muscular weakness—Thalidomide—leprosy	0.000579	0.00409	CcSEcCtD
Delavirdine—Abdominal distension—Thalidomide—leprosy	0.000571	0.00404	CcSEcCtD
Delavirdine—Insomnia—Dapsone—leprosy	0.00057	0.00403	CcSEcCtD
Delavirdine—Dysphagia—Thalidomide—leprosy	0.000567	0.00401	CcSEcCtD
Delavirdine—Influenza—Thalidomide—leprosy	0.000567	0.00401	CcSEcCtD
Delavirdine—Eosinophilia—Thalidomide—leprosy	0.000562	0.00397	CcSEcCtD
Delavirdine—Pancreatitis—Thalidomide—leprosy	0.000556	0.00393	CcSEcCtD
Delavirdine—Bronchitis—Thalidomide—leprosy	0.000545	0.00386	CcSEcCtD
Delavirdine—Pancytopenia—Thalidomide—leprosy	0.000539	0.00381	CcSEcCtD
Delavirdine—Neutropenia—Thalidomide—leprosy	0.00053	0.00375	CcSEcCtD
Delavirdine—Upper respiratory tract infection—Thalidomide—leprosy	0.000527	0.00373	CcSEcCtD
Delavirdine—Erectile dysfunction—Thalidomide—leprosy	0.000522	0.0037	CcSEcCtD
Delavirdine—Weight increased—Thalidomide—leprosy	0.000516	0.00365	CcSEcCtD
Delavirdine—Gastrointestinal pain—Dapsone—leprosy	0.000515	0.00365	CcSEcCtD
Delavirdine—Hyperglycaemia—Thalidomide—leprosy	0.000512	0.00362	CcSEcCtD
Delavirdine—Pneumonia—Thalidomide—leprosy	0.000509	0.0036	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000501	0.00355	CcSEcCtD
Delavirdine—Abdominal pain—Dapsone—leprosy	0.000498	0.00352	CcSEcCtD
Delavirdine—Body temperature increased—Dapsone—leprosy	0.000498	0.00352	CcSEcCtD
Delavirdine—Neuropathy peripheral—Thalidomide—leprosy	0.000496	0.00351	CcSEcCtD
Delavirdine—Stomatitis—Thalidomide—leprosy	0.000493	0.00349	CcSEcCtD
Delavirdine—Conjunctivitis—Thalidomide—leprosy	0.000492	0.00348	CcSEcCtD
Delavirdine—Haematuria—Thalidomide—leprosy	0.000482	0.00341	CcSEcCtD
Delavirdine—Epistaxis—Thalidomide—leprosy	0.000477	0.00337	CcSEcCtD
Delavirdine—Sinusitis—Thalidomide—leprosy	0.000474	0.00336	CcSEcCtD
Delavirdine—Bradycardia—Thalidomide—leprosy	0.000462	0.00327	CcSEcCtD
Delavirdine—Rhinitis—Thalidomide—leprosy	0.000455	0.00322	CcSEcCtD
Delavirdine—Hepatitis—Thalidomide—leprosy	0.000454	0.00321	CcSEcCtD
Delavirdine—Hypoaesthesia—Thalidomide—leprosy	0.000452	0.0032	CcSEcCtD
Delavirdine—Pharyngitis—Thalidomide—leprosy	0.000451	0.00319	CcSEcCtD
Delavirdine—Oedema peripheral—Thalidomide—leprosy	0.000447	0.00316	CcSEcCtD
Delavirdine—Erythema multiforme—Thalidomide—leprosy	0.000429	0.00304	CcSEcCtD
Delavirdine—Tinnitus—Thalidomide—leprosy	0.000423	0.00299	CcSEcCtD
Delavirdine—Chills—Thalidomide—leprosy	0.000407	0.00288	CcSEcCtD
Delavirdine—Alopecia—Thalidomide—leprosy	0.000401	0.00284	CcSEcCtD
Delavirdine—Vomiting—Dapsone—leprosy	0.000401	0.00283	CcSEcCtD
Delavirdine—Malnutrition—Thalidomide—leprosy	0.000395	0.0028	CcSEcCtD
Delavirdine—Headache—Dapsone—leprosy	0.000395	0.00279	CcSEcCtD
Delavirdine—Flatulence—Thalidomide—leprosy	0.000389	0.00276	CcSEcCtD
Delavirdine—Tension—Thalidomide—leprosy	0.000388	0.00274	CcSEcCtD
Delavirdine—Dysgeusia—Thalidomide—leprosy	0.000387	0.00274	CcSEcCtD
Delavirdine—Nervousness—Thalidomide—leprosy	0.000384	0.00272	CcSEcCtD
Delavirdine—Back pain—Thalidomide—leprosy	0.000382	0.0027	CcSEcCtD
Delavirdine—Muscle spasms—Thalidomide—leprosy	0.00038	0.00269	CcSEcCtD
Delavirdine—Nausea—Dapsone—leprosy	0.000374	0.00265	CcSEcCtD
Delavirdine—Vision blurred—Thalidomide—leprosy	0.000372	0.00264	CcSEcCtD
Delavirdine—Tremor—Thalidomide—leprosy	0.00037	0.00262	CcSEcCtD
Delavirdine—Ill-defined disorder—Thalidomide—leprosy	0.000367	0.00259	CcSEcCtD
Delavirdine—Anaemia—Thalidomide—leprosy	0.000365	0.00258	CcSEcCtD
Delavirdine—Agitation—Thalidomide—leprosy	0.000363	0.00257	CcSEcCtD
Delavirdine—Angioedema—Thalidomide—leprosy	0.000361	0.00255	CcSEcCtD
Delavirdine—Malaise—Thalidomide—leprosy	0.000356	0.00252	CcSEcCtD
Delavirdine—Vertigo—Thalidomide—leprosy	0.000355	0.00251	CcSEcCtD
Delavirdine—Syncope—Thalidomide—leprosy	0.000354	0.00251	CcSEcCtD
Delavirdine—Leukopenia—Thalidomide—leprosy	0.000354	0.0025	CcSEcCtD
Delavirdine—Palpitations—Thalidomide—leprosy	0.000349	0.00247	CcSEcCtD
Delavirdine—Loss of consciousness—Thalidomide—leprosy	0.000347	0.00246	CcSEcCtD
Delavirdine—Cough—Thalidomide—leprosy	0.000345	0.00244	CcSEcCtD
Delavirdine—Hypertension—Thalidomide—leprosy	0.000341	0.00241	CcSEcCtD
Delavirdine—Myalgia—Thalidomide—leprosy	0.000336	0.00238	CcSEcCtD
Delavirdine—Arthralgia—Thalidomide—leprosy	0.000336	0.00238	CcSEcCtD
Delavirdine—Chest pain—Thalidomide—leprosy	0.000336	0.00238	CcSEcCtD
Delavirdine—Anxiety—Thalidomide—leprosy	0.000335	0.00237	CcSEcCtD
Delavirdine—Discomfort—Thalidomide—leprosy	0.000332	0.00235	CcSEcCtD
Delavirdine—Dry mouth—Thalidomide—leprosy	0.000329	0.00233	CcSEcCtD
Delavirdine—Confusional state—Thalidomide—leprosy	0.000325	0.0023	CcSEcCtD
Delavirdine—Oedema—Thalidomide—leprosy	0.000323	0.00228	CcSEcCtD
Delavirdine—Infection—Thalidomide—leprosy	0.00032	0.00227	CcSEcCtD
Delavirdine—Shock—Thalidomide—leprosy	0.000317	0.00225	CcSEcCtD
Delavirdine—Thrombocytopenia—Thalidomide—leprosy	0.000316	0.00223	CcSEcCtD
Delavirdine—Tachycardia—Thalidomide—leprosy	0.000315	0.00223	CcSEcCtD
Delavirdine—Skin disorder—Thalidomide—leprosy	0.000313	0.00222	CcSEcCtD
Delavirdine—Hyperhidrosis—Thalidomide—leprosy	0.000312	0.00221	CcSEcCtD
Delavirdine—Anorexia—Thalidomide—leprosy	0.000307	0.00218	CcSEcCtD
Delavirdine—Hypotension—Thalidomide—leprosy	0.000301	0.00213	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000294	0.00208	CcSEcCtD
Delavirdine—Insomnia—Thalidomide—leprosy	0.000292	0.00206	CcSEcCtD
Delavirdine—Paraesthesia—Thalidomide—leprosy	0.00029	0.00205	CcSEcCtD
Delavirdine—Dyspnoea—Thalidomide—leprosy	0.000288	0.00203	CcSEcCtD
Delavirdine—Somnolence—Thalidomide—leprosy	0.000287	0.00203	CcSEcCtD
Delavirdine—Dyspepsia—Thalidomide—leprosy	0.000284	0.00201	CcSEcCtD
Delavirdine—Decreased appetite—Thalidomide—leprosy	0.00028	0.00198	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Thalidomide—leprosy	0.000278	0.00197	CcSEcCtD
Delavirdine—Fatigue—Thalidomide—leprosy	0.000278	0.00197	CcSEcCtD
Delavirdine—Pain—Thalidomide—leprosy	0.000276	0.00195	CcSEcCtD
Delavirdine—Constipation—Thalidomide—leprosy	0.000276	0.00195	CcSEcCtD
Delavirdine—Feeling abnormal—Thalidomide—leprosy	0.000266	0.00188	CcSEcCtD
Delavirdine—Gastrointestinal pain—Thalidomide—leprosy	0.000264	0.00187	CcSEcCtD
Delavirdine—Urticaria—Thalidomide—leprosy	0.000256	0.00181	CcSEcCtD
Delavirdine—Abdominal pain—Thalidomide—leprosy	0.000255	0.0018	CcSEcCtD
Delavirdine—Body temperature increased—Thalidomide—leprosy	0.000255	0.0018	CcSEcCtD
Delavirdine—Hypersensitivity—Thalidomide—leprosy	0.000238	0.00168	CcSEcCtD
Delavirdine—Asthenia—Thalidomide—leprosy	0.000231	0.00164	CcSEcCtD
Delavirdine—Pruritus—Thalidomide—leprosy	0.000228	0.00161	CcSEcCtD
Delavirdine—Diarrhoea—Thalidomide—leprosy	0.000221	0.00156	CcSEcCtD
Delavirdine—Dizziness—Thalidomide—leprosy	0.000213	0.00151	CcSEcCtD
Delavirdine—Vomiting—Thalidomide—leprosy	0.000205	0.00145	CcSEcCtD
Delavirdine—Rash—Thalidomide—leprosy	0.000203	0.00144	CcSEcCtD
Delavirdine—Dermatitis—Thalidomide—leprosy	0.000203	0.00144	CcSEcCtD
Delavirdine—Headache—Thalidomide—leprosy	0.000202	0.00143	CcSEcCtD
Delavirdine—Nausea—Thalidomide—leprosy	0.000192	0.00136	CcSEcCtD
